Wang Mingbang, Wan Jing, Rong Han, He Fusheng, Wang Hui, Zhou Jiaxiu, Cai Chunquan, Wang Yan, Xu Ruihuan, Yin Zhaoqing, Zhou Wenhao
Shanghai Key Laboratory of Birth Defects, Division of Neonatology, Children's Hospital of Fudan University, National Center for Children's Health, Shanghai, China.
Division of Neonatology, The People's Hospital of Dehong Autonomous Prefecture, Mangshi, Yunnan, China.
mSystems. 2019 Jan 29;4(1). doi: 10.1128/mSystems.00321-18. eCollection 2019 Jan-Feb.
Changes in the gut microenvironment may influence the pathogenesis of autism spectrum disorders (ASD). Here, we investigated the composition of the gut microbiota and metabolites in children with ASD. Ninety-two children with ASD and 42 age-matched children exhibiting typical development (TD) were enrolled in the two-stage study. In the discovery stage, shotgun metagenomic sequencing and liquid chromatography-mass spectrometry (LC-MS) were performed simultaneously on fecal samples obtained from 43 children in the ASD group and 31 children in the TD group. Systematic bioinformatic analyses were performed to identify gut metabolites associated with altered gut microbiota composition. At the validation stage, differential metabolites were tested using LC-MS with an additional 49 and 11 children in the ASD and TD groups, respectively. Altered glutamate metabolites were found in the ASD group, along with a decline in 2-keto-glutaramic acid and an abundance of microbiota associated with glutamate metabolism. These changes in glutamate metabolism were correlated with lower levels of the highly abundant bacteria Bacteroides vulgatus and higher levels of the potentially harmful Eggerthella lenta and Clostridium botulinum. Lower gut cortisol levels have also been identified in the ASD group and associated with changes in gut microbiota glutamate metabolism. Finally, gut 2-keto-glutaramic acid was validated as a potential biomarker for ASD. The significant changes in the gut microenvironment in children with ASD may provide new insight into the cause of ASD and aid in the search for diagnostic and therapeutic approaches. Multiple lines of evidence suggest that the gut microbiota may play an important role in the pathogenesis of ASD, but the specific mechanism is still unclear. Through a comprehensive gut metagenomic and metabolome study of children with ASD, alterations in gut metabolite composition were found in children with ASD, and these alterations were linked to changes in gut microbiota composition. This may give us a deeper understanding of the role of gut microbiota in the pathogenesis of ASD.
肠道微环境的变化可能会影响自闭症谱系障碍(ASD)的发病机制。在此,我们研究了ASD患儿的肠道微生物群和代谢产物的组成。92名ASD患儿和42名年龄匹配的发育正常(TD)儿童参与了这项两阶段研究。在发现阶段,对来自ASD组的43名儿童和TD组的31名儿童的粪便样本同时进行了鸟枪法宏基因组测序和液相色谱-质谱联用(LC-MS)分析。进行了系统的生物信息学分析,以鉴定与肠道微生物群组成改变相关的肠道代谢产物。在验证阶段,分别对ASD组和TD组另外49名和11名儿童使用LC-MS对差异代谢产物进行了检测。在ASD组中发现谷氨酸代谢产物发生了改变,同时2-酮戊二酸含量下降,且存在大量与谷氨酸代谢相关的微生物群。谷氨酸代谢的这些变化与高丰度细菌普通拟杆菌水平降低以及潜在有害菌迟缓埃格特菌和肉毒梭菌水平升高有关。在ASD组中还发现肠道皮质醇水平较低,且与肠道微生物群谷氨酸代谢的变化有关。最后,肠道2-酮戊二酸被验证为ASD的潜在生物标志物。ASD患儿肠道微环境的显著变化可能为ASD的病因提供新的见解,并有助于寻找诊断和治疗方法。多条证据表明肠道微生物群可能在ASD的发病机制中起重要作用,但具体机制仍不清楚。通过对ASD患儿进行全面的肠道宏基因组和代谢组研究,发现ASD患儿肠道代谢产物组成发生了改变,且这些改变与肠道微生物群组成的变化有关。这可能使我们对肠道微生物群在ASD发病机制中的作用有更深入的了解。